A Phase 2 interventional study of 0.5% Ivermectin lotion and Vehicle in Pediculosis Capitis, sponsored by United Laboratories. Completed at 1 site in Philippines. Open to participants aged 3 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-03-07.
Sponsored by United Laboratories · Phase 2, Interventional, and Treatment
This is a randomized, double-blind, placebo-controlled clinical study evaluating the efficacy and safety of a single application of 0.5% ivermectin lotion in Filipino subjects with head lice.
Exclusion Criteria:
Drug: 0.5% Ivermectin lotion
Drug: Vehicle
The intervention is composed of a single application of the 0.5% ivermectin lotion.
The intervention is composed of a single application of the vehicle control.
Proportion of participants cured of head lice infestation from their assigned product on day 2, day 8 and day 15 after the first treatment.
Time frame: Day 2 to day 15 after product application
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
United Laboratories